Chief Financial Officer · Atara Biotherapeutics, Inc. (ATRA)

Utpal Koppikar

A named executive officer of Atara Biotherapeutics in every fiscal year CompBrief holds from FY2018 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$2,224,682

Salary $475,096Stock awards $774,138

FY2020: $2,137,953

3rd of 5 named executive officers at Atara Biotherapeutics by FY2021 total.

5 named officers on file for Atara Biotherapeutics, FY2021

Utpal Koppikar’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 6 equity grants, each cited to its filing
  • ATRA’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Atara Biotherapeutics’s whole pay program stands against its peers

  • Atara Biotherapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ATRA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 27, 2022 (DEF 14A).

Free

Get Utpal Koppikar’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Utpal Koppikar compensation by year

Atara Biotherapeutics Summary Compensation Table · all 4 fiscal years held
In US dollars, as Atara Biotherapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018FY2019FY2020FY2021
Salary$240,289$439,875$460,947$475,096
Bonus$189,771$0$0$0
Stock awards$1,903,500$1,034,714$885,431$774,138
Option awards$1,886,325$909,080$597,073$774,155
Non-equity incentive$0$155,606$187,032$188,248
Pension and deferred compensation$0$0$0$0
All other$398$895$7,470$13,045
Total$4,220,282$2,540,170$2,137,953$2,224,682

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Atara Biotherapeutics, Inc. DEF 14A filed April 27, 2022, accession 0001564590-22-016087, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Atara Biotherapeutics, Inc. filed document, accession 0001564590-22-016087. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2022.

$4.2M
$2.5M
$2.1M
$2.2M
FY18
FY19
FY20
FY21
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
RSU37,622$592,923—
RSU36,774$579,558—
RSU8,531$134,449—
PSU6,750$106,380—
Option9,375—$42.30
Option55,505—$17.11
Option9,953—$38.47
Option41,484—$12.15

Per the Outstanding Equity Awards at Fiscal Year-End table in Atara Biotherapeutics, Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Atara Biotherapeutics’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Pascal TouchonPresident & Chief Executive Officer$5,117,335
Jakob DupontEVP, Global Head of Research and Development$2,728,269
Utpal Koppikar · this pageChief Financial Officer$2,224,682
Amar MuruganSVP, General Counsel$2,040,252
Kristin YaremaSVP, Chief Commercial Officer$1,889,494

The full Atara Biotherapeutics compensation record

free company brief

This page is one person within Atara Biotherapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Atara Biotherapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Atara Biotherapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Utpal Koppikar's compensation dossier · One-time report. No refunds.